386715-34-0 Usage
Uses
Used in Pharmaceutical Industry:
6-(TRIFLUOROMETHYL)THIONICOTINAMIDE is used as a starting material for the preparation of phenyloxadiazolone derivatives, which are known for their diverse range of biological activities and potential applications in the development of new drugs. These derivatives have shown promise in various therapeutic areas, including anti-inflammatory, anti-cancer, and anti-infective properties.
Used in Chemical Research:
In the field of chemical research, 6-(TRIFLUOROMETHYL)THIONICOTINAMIDE is utilized as a synthetic intermediate for the development of novel compounds with potential applications in various industries. Its unique structure allows for further functionalization and modification, enabling the creation of new molecules with tailored properties and functions.
Used in Material Science:
6-(TRIFLUOROMETHYL)THIONICOTINAMIDE may also find applications in the field of material science, where its properties can be exploited to develop new materials with specific characteristics. For instance, its incorporation into polymers or other materials could lead to the creation of materials with enhanced properties, such as improved stability, reactivity, or selectivity in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 386715-34-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,6,7,1 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 386715-34:
(8*3)+(7*8)+(6*6)+(5*7)+(4*1)+(3*5)+(2*3)+(1*4)=180
180 % 10 = 0
So 386715-34-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5F3N2S/c8-7(9,10)5-2-1-4(3-12-5)6(11)13/h1-3H,(H2,11,13)
386715-34-0Relevant articles and documents
Phenyl-1,2,4-Oxadiazolone Derivatives, Processes For Their Preparation and Methods For Their Use as Pharmaceuticals
-
Page/Page column 58, (2008/12/04)
The inventive compounds of the present invention are comprised of phenyl and pyridinyl-1,2,4-oxadiazolone derivatives and their physiologically acceptable salts and functional derivatives that are shown to provide peroxisome proliferator activator recepto
